Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3299PDF: 1462HTML: 3996 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3666PDF: 1433HTML: 181 -
Leukocyte derived chemotaxin 2 (ALECT2) amyloidosis
1556PDF: 769HTML: 1299 -
-
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2797PDF: 942HTML: 7330 -
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1095PDF: 485HTML: 8162 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2769PDF: 1011HTML: 360Preferred Reviewers: 204 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2085PDF: 985HTML: 4067Cover Letter: 218Figure 1: 228Figure 2: 227Table 1: 201 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2208PDF: 959HTML: 1889 -
Major Artery Occlusion: a Rare Complication of Sickle Cell Disease
1352PDF: 1031HTML: 4601 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1014PDF: 608HTML: 73 -
CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN
2503PDF: 942HTML: 2227 -
AN INEXPENSIVE CLINICAL-LABORATORY NOMOGRAM TO PREDICT POST-TREATMENT LUNG DESTRUCTION IN PULMONARY TUBERCULOSIS
548PDF: 257Suppl. Files: 69Html: 42 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3364PDF: 1288HTML: 1861Fig.1: 198Fig. 2: 203 -
PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.
2474PDF: 1152HTML: 11795 -
EPIDEMIOLOGY OF IMPORTED MALARIA IN THE MEDITERRANEAN REGION
3106PDF: 1039HTML: 16412 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2572PDF: 797HTML: 5207 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
716PDF: 463HTML: 6263 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2156PDF: 1577HTML: 262 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1227PDF: 974HTML: 206 -
THE IMPACT OF HUMAN PLATELET ANTIGEN ALLELE ON ANTIPLATELET ANTIBODIES AND CRYOGLOBULINS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA AND HEPATITIS C VIRUS-ASSOCIATED IMMUNE THROMBOCYTOPENIA Human platelet antigen and immune thrombocytopenia
999PDF: 855Suppl. Files: 455HTML: 283 -
SERO PREVALENCE OF TOXARA CANIS IN THE CITY OF CATANIA, ITALY.
1354PDF: 939HTML: 219 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3360PDF: 1277HTML: 2212Fi.1 Gritti.Rambaldi: 203 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12329PDF: 1672HTML: 4163Cover letter: 196Figure 1: 202 -
AGE AT DIAGNOSIS OF SICKLE CELL ANAEMIA IN LAGOS, NIGERIA
1967PDF: 894HTML: 1861 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1821HTML: 1431PDF: 1078 -
-
The labyrinth of pyrexia of unknown origin: A case of intravascular B cell lymphoma
1765PDF: 683HTML: 2404Untitled: 151Figure 1 a: 154Figure 1 b: 164Fig 1 c: 146Figure 1 d: 192 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1671PDF: 801HTML: 934cover letter: 263 -
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES. Hematopoietic stem cell transplatation in the elderly fo Acute Myeloid Leukemia
1568PDF: 500HTML: 157 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2209PDF: 1037HTML: 1981Characteristic of study group: 196







